Re-engineering a $4 billion company for the age of AI Linda Tong, CEO at Weblow
Sep 24, 2026 - 44:41
Radio and PodcastLive Radio & Podcasts
Business
Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon
Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate—only to see it fail in human trials. In...
Related Episodes
Continue listening to more episodes from Innovation and Leadership with Jess Larsen.
Infiltrating Biker Gangs & Cartels for the CIA Matthew Hedger
Sep 17, 2026 - 62:58
How Did He Grow to $18B Seth Streeter, Co-Founder of Mission Wealth
Sep 3, 2026 - 50:07
How Did He Build A $1.5B Licensing Portfolio Sam Bremner
Aug 28, 2026 - 62:46
Investing in the Future of AI CyberSercurity Andrew Rubin, Illumio Founder & CEO
Aug 20, 2026 - 59:57
How did He Grow to $6.4B Tom Shea, Co-Founder & CEO of Onestream
Aug 14, 2026 - 46:57
Fomer Undercover CIA Officer Rescuing Children Founder and President, ARC
Aug 6, 2026 - 64:49
